Researcher
Michiel THOMEER
- Keywords:Medicine, Biomedical sciences (incl. biochemistry)
- Disciplines:Cancer biology, Cancer diagnosis, Cancer prevention, Cancer therapy
Affiliations
- Cardio & organ systems (Department)
Member
From1 Jan 2020 → Today - Cardio & organ systems (Research group)
Member
From1 Jan 2020 → Today - Limburg Clinical Research Center (Research Center)
Member
From1 Jan 2020 → Today - Faculty of Medicine and Life Sciences (Faculty)
Member
From1 Oct 2009 → Today - Immunology - Biochemistry (Research group)
Member
From1 Sep 2012 → 31 Dec 2019 - Physiology - Biochemistry - Immunology (Department)
Member
From1 Oct 2009 → 31 Dec 2019
Projects
1 - 4 of 4
- Combining PETCT with a glutamate based blood test improves cancer diagnosis in solitary pulmonary nodules.From1 Oct 2021 → TodayFunding: Nonprofit institution or equivalents
- Future proof pathology for predictive medicine and disease prognosis based on tumor heterogeneity.From1 Jan 2021 → TodayFunding: BOF - projects
- Towards better therapy for resectable lung cancer: Metabolomics predict therapy responseFrom1 Dec 2017 → 30 Nov 2022Funding: Nonprofit institution or equivalents
- Quantifying tumor heterogeneity in lung cancer: novel insights from non-invasive imaging techniques.From1 Oct 2014 → 30 Apr 2015Funding: BOF - Doctoral projects
Publications
11 - 20 of 66
- Modulation of thromboinflammation in hospitalized COVID-19 patients with aprotinin, low molecular weight heparin, and anakinra: The DAWn-Antico study(2022)
Authors: Matthias M. Engelen, Quentin Van Thillo, Albrecht Betrains, Iwein Gyselinck, Caroline P. Martens, Valerie Spalart, Anna Ockerman, Caroline Devooght, Joost Wauters, Jan Gunst, et al.
- HLA-I diversity and tumor mutational burden by comprehensive next-generation sequencing as predictive biomarkers for the treatment of non-small cell lung cancer with PD-(L)1 inhibitors(2022)
Authors: Kristof CUPPENS, Paul Baas, Ellen GEERDENS, Bert Cruys, Guy FROYEN, Lynn Decoster, Michiel THOMEER, Brigitte MAES
Pages: 1 - 10 - Remote patient monitoring in COVID-19: a critical appraisal(2022)
Authors: Henri GRUWEZ, Emma Bakelants, Pauline DREESEN, Jolien Broekmans, Maarten Criel, Michiel THOMEER, Pieter VANDERVOORT, David RUTTENS
- Changes in Metabolism as a Diagnostic Tool for Lung Cancer: Systematic Review(2022)
Authors: Hanne MARIEN, Elien DERVEAUX, Karolien VANHOVE, Peter ADRIAENSENS, Michiel THOMEER, Liesbet MESOTTEN
- Modulation of thromboinflammation in hospitalized COVID-19 patients with aprotinin, low molecular weight heparin, and anakinra: The DAWn-Antico study(2022)
Authors: Matthias M Engelen, Quentin Van Thillo, Albrecht Betrains, Iwein Gyselinck, Caroline P Martens, Valérie Spalart, Anna Ockerman, Caroline Devooght, Joost Wauters, Jan Gunst, et al.
Pages: e12826 - Physical activity during and after a severe acute exacerbation of COPD(2021)
Authors: Kirsten QUADFLIEG, A. Machado, F. De Lima, Marc DAENEN, David RUTTENS, Michiel THOMEER, Martijn A. SPRUIT, Chris BURTIN
- Understanding omics data of lung cancer patients: Correlations between metabolomics and radiomics(2021)
Authors: Liesbet MESOTTEN, L. Deckers, R. Truyens, Elien DERVEAUX, Peter ADRIAENSENS, Michiel THOMEER, R. Boellaard
- Detection of Lung Cancer via Blood Plasma and 1H-NMR Metabolomics: Validation by a Semi-Targeted and Quantitative Approach Using a Protein-Binding Competitor(2021)
Authors: Elien DERVEAUX, Michiel THOMEER, Liesbet MESOTTEN, Gunter REEKMANS, Peter ADRIAENSENS
- Repeatability of two semi-automatic artificial intelligence approaches for tumor segmentation in PET(2021)
Authors: Elisabeth Pfaehler, Liesbet MESOTTEN, Gem Kramer, Michiel THOMEER, Karolien VANHOVE, Johan de Jong, Peter ADRIAENSENS, Otto S Hoekstra, Ronald Boellaard
- Physical Tests Are Poorly Related to Patient-Reported Outcome Measures during Severe Acute Exacerbations of COPD(2021)
Authors: Kirsten QUADFLIEG, Ana Machado, Sarah HAESEVOETS, Marc DAENEN, Michiel THOMEER, David RUTTENS, Martijn A. SPRUIT, Chris BURTIN